Sionna Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Sionna Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, with key proposals including director elections and auditor ratification.
NASDAQ
Sionna Therapeutics announces its 2025 Annual Meeting of Stockholders, featuring director elections and ratification of the independent accounting firm.
NASDAQ
Sionna Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 12, 2025, featuring proposals for director elections and auditor ratification.